Balyasny Asset Management »

Day One Biopharmaceuticals I shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Day One Biopharmaceuticals I (DAWN) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Day One Biopharmaceuticals I

Tip: Access up to 7 years of quarterly data

All positions including Day One Biopharmaceuticals I held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Day One Biopharmaceuticals I by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.8M 1.4M 7.05
2025-03-31 $1.1M 134k 7.93
2024-12-31 $373k 30k 12.67
2024-03-31 $878k 53k 16.52
2023-12-31 $228k 16k 14.60
2022-12-31 $213k 9.9k 21.52

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Tesla Motors Call Option (TSLA)
Select Sector Spdr Tr Financial (XLF)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Gold Miners Etf (GDX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Visa Com Cl A Call Option (V)
Wolfspeed Common Stock (WOLF)

View all positions for Balyasny Asset Management

Top funds holding Day One Biopharmaceuticals I

FMR
BlackRock
Atlas Venture Life Science Advisors
Vanguard Group
Deerfield Management Company
Franklin Resources
Rubric Capital Management
State Street Corporation
Vestal Point Capital
Pictet Asset Management Holding SA
Alyeska Investment Group
Braidwell
Geode Capital Management
AIGH Capital Management
MAK Capital One

View all funds holding Day One Biopharmaceuticals I